UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (USD $) In Thousands	Total	Common Stock	Additional Paid-In Capitol	Accumulated Other Comprehensive Income	Retained Earnings
Balance, value at Dec. 31, 2011	$ 40,756	$ 36	$ 721	$ (2,906)	$ 42,905
Balance, shares at Dec. 31, 2011		3,640
Common stock issued upon exercise of employee stock options	1,941	1	1,940
Common stock issued upon exercise of employee stock options, shares		82
Common stock received and retired upon exercise of stock options	(138)	0	(138)
Common stock received and retired upon exercise of stock options, shares		(4)
Tax benefit attributable to appreciation of stock options	178		178
Stock option compensation expense	70		70
Common stock purchased and retired	(504)	0	(503)
Common stock purchased and retired, shares		(15)
Foreign currency translation adjustment	1,862			1,862
Unrealized holding gain (loss) from investments, available-for-sale, net of taxes	193			193
Common stock dividends	(3,555)				(3,555)
Net income	10,169				10,169
Balance, value at Dec. 31, 2012	50,972	37	2,268	(851)	49,519
Balance, shares at Dec. 31, 2012		3,703
Common stock issued upon exercise of employee stock options	1,403	1	1,402
Common stock issued upon exercise of employee stock options, shares		55
Common stock received and retired upon exercise of stock options	(701)	0	(701)
Common stock received and retired upon exercise of stock options, shares		(15)
Tax benefit attributable to appreciation of stock options	281		281
Stock option compensation expense	28		28
Common stock purchased and retired	0
Foreign currency translation adjustment	859			859
Unrealized holding gain (loss) from investments, available-for-sale, net of taxes	8			8
Common stock dividends	(3,675)				(3,675)
Net income	11,406				11,406
Balance, value at Dec. 31, 2013	60,581	37	3,278	16	57,250
Balance, shares at Dec. 31, 2013		3,743
Common stock issued upon exercise of employee stock options	926	0	926
Common stock issued upon exercise of employee stock options, shares		35
Common stock received and retired upon exercise of stock options	(435)	0	(435)
Common stock received and retired upon exercise of stock options, shares		(8)
Tax benefit attributable to appreciation of stock options	103		103
Stock option compensation expense	74		74
Common stock purchased and retired	(1,055)	0	(1,055)
Common stock purchased and retired, shares		(22)
Foreign currency translation adjustment	(3,252)			(3,252)
Unrealized holding gain (loss) from investments, available-for-sale, net of taxes	1			1
Common stock dividends	(3,765)				(3,765)
Net income	11,378				11,378
Balance, value at Dec. 31, 2014	$ 64,556	$ 37	$ 2,890	$ (3,234)	$ 64,863
Balance, shares at Dec. 31, 2014		3,748